Literature DB >> 10468931

Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece.

I Tzavara1, B Vlassopoulou, C Alevizaki, G Koukoulis, M Tzanela, P Koumoussi, F Sotsiou, N Thalassinos.   

Abstract

OBJECTIVE: To analyse the initial manifestations, pathological findings, therapy, outcome and prognostic factors in patients with papillary and follicular carcinoma. PATIENTS: 832 patients with well differentiated thyroid carcinoma managed in our department during a period of 30 years (1965-1995). Follow-up data were available for 609 patients for a mean of 5.5 years (range 1-38 years), the remainder having been lost to follow-up.
RESULTS: The patients were 677 (81%) with papillary and 155 with follicular carcinoma. They were predominantly female (75%), presenting mainly with a single nodule (53%), while at the time of diagnosis 72% had intrathyroidal carcinomas (class I), 17% had nodal metastases (class II), 7% soft tissue invasion (class III) and 4% distant metastases (class IV). Fifty-five percent of the patients had a complete thyroidectomy (36% had a near total or total thyroidectomy and 19% near total or total thyroidectomy plus block dissection), 2.6% received external radiotherapy and 94% had radioactive iodine as part of the treatment of the original disease. Kaplan-Meier survival analysis was used to calculate both cancer related mortality and disease free survival in the patients followed-up. Although mortality (21 cancer-related deaths) was slightly higher for follicular than papillary carcinoma (10% vs. 5% and 16% vs. 10% in 10- and 15-year survival, respectively) the difference was not statistically significant. Extent of disease at diagnosis, male sex, tumour size and age > 60 years affected probability of cancer death. Cox's proportional hazard regression analysis for disease free survival showed that adverse independent prognostic factors were, for papillary carcinoma, male sex, class II or higher, tumour size > 1 cm and age > 60 years, while for follicular, class III or higher, size > 4 cm and age > 40 years.
CONCLUSIONS: We conclude that there is a higher prevalence of follicular carcinoma in our country probably due to a moderate degree of iodine deficiency still existing in Greece. Age and extent of disease at diagnosis were important prognostic factors affecting morbidity and mortality, whereas sex, tumour features and histological type were of minor importance. All these prognostic factors and their relative importance should be taken in consideration in the management of this disease.

Entities:  

Mesh:

Year:  1999        PMID: 10468931     DOI: 10.1046/j.1365-2265.1999.00715.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Follicular adenoma and carcinoma of the thyroid gland.

Authors:  Christopher R McHenry; Roy Phitayakorn
Journal:  Oncologist       Date:  2011-04-11

2.  Retrospective analysis of predictive factors for recurrence after curatively resected papillary thyroid carcinoma.

Authors:  Katsuhiro Tanaka; Hiroshi Sonoo; Mai Hirono; Sumiko Ohkubo; Tsunehisa Nomura; Masahiko Ikeda; Kazukata Nakajima; Junichi Kurebayashi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.

Authors:  Panchagan Rama Kant Bhargav; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; Prasanta Kumar Pradhan; Sanjay Gambhir; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

4.  Changing patterns of thyroid carcinoma.

Authors:  B Dijkstra; R S Prichard; A Lee; L M Kelly; P P A Smyth; T Crotty; E W McDermott; A D K Hill; N O'Higgins
Journal:  Ir J Med Sci       Date:  2007-05-08       Impact factor: 1.568

5.  Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision.

Authors:  Agnieszka Czarniecka; Michal Jarzab; Jolanta Krajewska; Ewa Chmielik; Bogna Szcześniak-Klusek; Ewa Stobiecka; Robert Kokot; Aleksander Sacher; Stanisław Poltorak; Jan Wloch
Journal:  Thyroid Res       Date:  2010-10-29

6.  No considerable changes in papillary thyroid microcarcinoma characteristics over a 30-year time period.

Authors:  Varvara Vlassopoulou; Andromachi Vryonidou; Stavroula A Paschou; Dimitrios Ioannidis; Angeliki Koletti; Nikolaos Klonaris; Konstantinos Katsoulis; Dimitra Rontogianni; Charalampos Vasilopoulos; Stylianos Tsagarakis; Ioanna Tzavara
Journal:  BMC Res Notes       Date:  2016-04-29

7.  High rate of persistent/recurrent disease among patients with differentiated thyroid cancer in Saudi Arabia: factors affecting nonremission.

Authors:  Hussain Raef; Eman Alfadhli; Alya Al-Hajjaj; Usman H Malabu; Saif Al-Sobhi; Ayman Rifai; Abdulrahman Al Nuaim
Journal:  Ann Saudi Med       Date:  2008 Jul-Aug       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.